image
Healthcare - Biotechnology - NASDAQ - US
$ 0.315
-3.85 %
$ 12.1 M
Market Cap
-0.19
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
21.33%
EBIT Estimate
30.89%
Net Income Estimate
18.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Bolt Biotherapeutics, Inc.
image
BOLT has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart BOLT

image
$18.0m$18.0m$16.0m$16.0m$14.0m$14.0m$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart BOLT

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)($100.0m)($100.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart BOLT

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029